|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
40
|
|
pubmed:dateCreated |
2008-9-29
|
|
pubmed:abstractText |
Maurocalcine is a 33-mer peptide initially isolated from the venom of a Tunisian scorpion. It has proved itself valuable as a pharmacological activator of the ryanodine receptor and has helped the understanding of the molecular basis underlying excitation-contraction coupling in skeletal muscles. Because of its positively charged nature, it is also an innovative vector for the cell penetration of various compounds. We report a novel maurocalcine analog with improved properties: (i) the complete loss of pharmacological activity, (ii) preservation of the potent ability to carry cargo molecules into cells, and (iii) coupling chemistries not affected by the presence of internal cysteine residues of maurocalcine. We did this by replacing the six internal cysteine residues of maurocalcine by isosteric 2-aminobutyric acid residues and by adding an additional N-terminal biotinylated lysine (for a proof of concept analog) or an N-terminal cysteine residue (for a chemically competent coupling analogue). Additional replacement of a glutamate residue by alanyl at position 12 further improves the potency of these analogues. Coupling to several cargo molecules or nanoparticles are presented to illustrate the cell penetration potency and usefulness of these pharmacologically inactive analogs.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-10523411,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-10788477,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-10861934,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-10970898,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-11772414,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-12869557,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-12958203,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-15537872,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-15591063,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-15653689,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-16168650,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-16545341,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-16608262,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-16782801,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-17291197,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-17491023,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-17888395,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-2886565,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-6309780,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-7499390,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-9251808,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18621738-9675196
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0021-9258
|
|
pubmed:author |
pubmed-author:AndreottiNicolasN,
pubmed-author:ArouiSoniaS,
pubmed-author:DarbonHervéH,
pubmed-author:De WaardMichelM,
pubmed-author:JacquemondVincentV,
pubmed-author:PirolletFabienneF,
pubmed-author:RamNarendraN,
pubmed-author:RonjatMichelM,
pubmed-author:SabatierJean-MarcJM,
pubmed-author:Texier-NoguesIsabelleI,
pubmed-author:WeissNorbertN
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
3
|
|
pubmed:volume |
283
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
27048-56
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18621738-Animals,
pubmed-meshheading:18621738-CHO Cells,
pubmed-meshheading:18621738-Cricetinae,
pubmed-meshheading:18621738-Cricetulus,
pubmed-meshheading:18621738-Disulfides,
pubmed-meshheading:18621738-Drug Carriers,
pubmed-meshheading:18621738-Humans,
pubmed-meshheading:18621738-Mice,
pubmed-meshheading:18621738-Muscle, Skeletal,
pubmed-meshheading:18621738-Scorpion Venoms,
pubmed-meshheading:18621738-Scorpions
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells.
|
|
pubmed:affiliation |
Research Group 3 Calcium Channels, Functions, and Pathologies, Unité Inserm 836, Grenoble Institute of Neuroscience, Université Joseph Fourier, Site Santé, BP 170, 38042 Grenoble Cedex 09, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
